Clinical Trial Update: Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating protection from pulmonary embolism with the OptEase permanent filter; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• OptEase Permanent Filter

Snippet

Sponsor: Cordis US Corp. | Conditions: Pulmonary Embolism | Phase 4 | Status: COMPLETED